Eli Lilly's Medicare Drug Plan Update on Weight-Loss Medications
Eli Lilly's latest announcement on Medicare drug plans highlights the $50 cap on expenses for weight-loss medications. Learn more about the implications.
Medicare Prescription Payment Plan: A Vital Resource for Seniors
Discover how the Medicare Prescription Payment Plan benefits seniors with medication costs, yet struggles with low enrollment and awareness. Explore actionable solutions!
Rising Medicare Drug Prices: Impact on Costs and Strategies
Explore the impact of rising Medicare prices on prescription drugs. Understand challenges and proactive strategies for insurers and policymakers.
Medicare Part D Changes: Projected Cost Savings and Coverage Updates
Discover anticipated changes to Medicare Part D in 2026, focusing on cost savings and regulatory updates that enhance prescription drug coverage for beneficiaries.
Medicare Prescription Drug Plan Market Faces Financial Pressure and Rising Subsidies
Medicare Part D drug plan market under financial stress as taxpayers fund record-level subsidies to health insurers amid rising costs and program challenges.
House GOP Proposes ACA Subsidy Extension and Health Insurance Reforms
House Republican leaders propose a healthcare bill to extend ACA subsidies, reduce premiums for low-income individuals, and increase prescription drug price transparency amid rising insurance costs.
Federal Government Allocates $16B to Medicare Drug Plans Amid Rising Costs
The U.S. federal government has paid $16 billion to Medicare Part D insurers due to rising prescription drug spending, highlighting cost and risk management challenges in Medicare drug plans.
Medicare Drug Price Negotiations Yield Significant Savings for 15 Key Medications
Pharmaceutical companies agree to reduce Medicare prices for 15 prescription drugs, potentially saving billions in taxpayer and patient costs under new negotiation rules starting in 2027.
Bipartisan HELP Copays Act Targets Prescription Drug Cost Relief
The HELP Copays Act aims to reduce prescription drug costs by ensuring copay assistance counts toward patients' deductibles and out-of-pocket limits, promoting insurance transparency and affordability.
Medicare Part D Plans Shrinking as Medicare Advantage Enrollment Grows
Medicare Part D stand-alone drug plans decline as enrollment in Medicare Advantage with drug coverage rises, reshaping market options for 2026.